ABSTRACT. The existence of P-nerve growth factor NGF-antiserum disrupts the ultrastructure and impairs several (PNGF) in mouse cerebral cortical synaptosomal extracts biochemical functions leading to the death of the target neurons was assessed using a newly developed radioimmunoasay (5-7). These results provide unambiguous evidence in support and by bioassay. Displacement curves of labeled PNGF in of a survival and maintenance role for NGF in neurons of the the radioimmunoassay by synaptosomal extracts were par-peripheral nervous system. allel to the BNGF standard curves. In contrast, both miIn contrast, the nature of NGF target neurons in the CNS is tochondrial and nonsynaptosomal extracts produced dis-not clear. The findings that exogenous NGF stimulates regenerplacement curves in the PNGF radioimmunoassay which ative growth of central noradrenergic neurons and that anti-NGF were nonparallel to standard BNGF. Intraventricular injec-inhibits this NGF-stimulated regenerative growth indicate that tions of purified BNGF in amounts 5 and 100 nglmouse central catecholaminergic neurons may acquire NGF responsive-(six to 120 times that of whole brain PNGF concentrations) ness during repair and regeneration processes (8, 9). Furtherdid not alter the endogenous synaptosomal BNGF concen-more, recent data indicating the ability of NGF to augment trations. Synaptosomal extracts contained PNGF in rela-choline acetyltransferase activity in neonatal and adult brain tively higher concentrations than the extracts of whole (10-12) and in aggregate brain cell culture systems (13) suggest brain or cerebral cortex. Synaptosomal PNGF levels that cholinergic neurons also may represent NGF-target neurons undergo a developmental change. The BNGF concentra-in the CNS. Retrograde axonal transport of NGF has been tions were highest in synaptosomal extracts of 12-day-old described in certain central cholinergic systems supporting the mouse cerebral cortex (the youngest age studied), and view that NGF may function in adult cholinergic neurons (14, levels decreased with increasing age. Synaptosomal ex-15). Despite the different PNGF biological responses, there is tracts of 12-day-old mouse cerebral cortex produced neu-considerable controversy regarding the location and amounts of rite outgrowth in the pheochromocytoma cell line 12 bioas-NGF present in the CNS (1 6-19).
All animals were sacrificed by C 0 2 narcosis which ensured death in less than 1 min. Care was taken during the dissection not to reuse the scissors and forceps used for removal of submandibular glands to cany out the dissections of brain and various brain regions.
Whole brains were removed and placed in a beaker containing 5 ml of 0.32 M ice cold sucrose. Brain tissues were rinsed at least three times with 5 ml of 0.32 M sucrose. During dissection, the whole brain was placed on a piece of glass plate overlying an ice bucket. The cortices were dissected free from adhering corpus callosum with fine forceps and scissor and immediately transferred to a beaker containing 0.32 M ice cold sucrose. Usually 2 to 2.5 g wet weight of cerebral cortex was pooled and three such pools for each age were individually processed for fractionation studies.
Isolation of synaptosomalfraction. For synaptosomal isolation the procedures described by Gray and Whittaker (23) and later by Levitan et al. (24) were modified as described below. Briefly, pooled cerebral cortical tissues were placed in 9 volumes of 0.32 M sucrose and cut into pieces with a fine scissor. The minced tissue was homogenized (three up and down strokes) gently by hand, and then by a motor driven homogenizer (400 rev/min, eight up and down strokes). Both hand homogenization and motor driven homogenizations were performed in a glass-Teflon homogenizer with a clearance of 0.25 mm. The homogenates were centrifuged as outlined in Figure 1A . The P2 pellet was resuspended in 0.32 M sucrose (5 ml/g original tissue), layered on a discontinuous sucrose density gradient consisting of equal layers of 1.2 and 0.8 M sucrose (12 ml each) and kept 1 h before use. Samples then were centrifuged at 75,000 x g for 120 min in a Beckman ultracentrifuge with a SW 25.1 rotor. The fractions between the 0.8 and 1.2 M sucrose interfaces were removed and diluted to 0.32 M sucrose by adding 0.16 M ice cold sucrose solution. The synaptosomal fractions were pelleted by centrifugation at 75,000 x g for 30 min. The supernatant solutions were discarded and the pellets resuspended in 0.05 M phosphate buffered saline (1 m1/2 g original tissue) and frozen at -70" C overnight. On the following day, the samples were thawed, transferred to a glass homogenizer, and homogenized (1 0 up and down strokes). The samples were centrifuged at 145,000 X g for 30 min using a 40.3 rotor. The clear supernatants, referred to as "synaptosomal extract," were used for quantification of PNGF. Protein content was measured by the method of Lowry el a[. (25) . Extraction of mitochondrial-rich fractions. For comparative purposes, we also extracted the P2C pellet (mitochondrial-enriched fraction) obtained from the discontinuous sucrose density gradient centrifugation. Homogenization and extraction were performed as described for the synaptosomal fractions.
Isolation of "nonsynaptosomal"fiaction. For studies of "nonsynaptosomal fractions," pooled cerebral cortices were subjected to initial homogenization in 0.25 M sucrose, a suboptimal condition for obtaining synaptosomal fractions. The 10% homoger-ate prepared in 0.25 M sucrose was centrifuged as outlined in Figure 1A for isolation of synaptosomal fractions. Isolation of synaptosomalfvaction after intraventricular injection of PNGF. To assess the extent of possible artifact in the measurement of synaptosomal PNGF concentrations, experiments were performed in animals that received intraventricular injections of purified PNGF preparation. The specific landmarks for intraventricular injection were standardized by injecting 3 p1 of India ink and studying the spread of the ink in animals sacrificed at different times. For these experiments, 21-day-old animals of similar body weights were chosen. In experiment 1, mice were injected intraventricularly with 5 ng PNGF dissolved in 3 p1 of saline; in experiment 2, 100 ng PNGF were injected in 3 p1 of saline. Animals were sacrificed 16 h after the injection. Cerebral cortices were separated and synaptosomal fractions isolated as described in Figure 1A .
Electron microscope technique. The fractions collected at the interface of 0.8 M and 1.2 M sucrose solutions were diluted with 10 volumes of 2.5% glutaraldehyde, pH 7.3, in 0.1 M sodium cacodylate buffer. The mixture was centrifuged at 50,000 x g for 30 min using a SW25.1 rotor. The supernatnat was discarded. The pellets were washed three times with 5 ml of the above buffer, and postfixed in buffered 1% osmium tetroxide for 30 min at 4" C. Pellets were dehydrated and embedded in Epon. Sections stained with toluidine Blue were cut at various levels and examined in a Hitachi H 1 -I I E electron microscope. Photographs were taken from the entire thickness of the pellet.
PNGF RIA. The PNGF antiserum used in the present study was developed in a rabbit by repeated intradermal injections of mouse submandibular gland PNGF prepared according to the method of Mobley et al. (26) as modified by Chapman et al. (27) . The same purified PNGF was iodinated by the chloramine T method of Greenwood et al. (28) . Labeled PNGF was purified as described in Grueters et al. (29) . The specific activity of 1251-PNGF determined by self displacement assay was 5.3 x lo6 Cil mol. The antiserum bound 50% 1251-PNGF at a final dilution of 1:250,000. Binding affinity of the antiserum for PNGF was estimated by Scatchard analysis. There were two populations of antibodies with Kd values of 7.6 x 10" and 7.0 x 101° mollliter. The mean Kd determined by Lineweaver-Burk plot was 1.7 x 10" mollliter. The RIA was performed using a liquid phase double antibody method. The buffer and assay protocol were as described by Walker et al. (30) , except that 1 h after the addition of goat antirabbit immunoglobulin, 60 p1 of 25% polyethylene glycol 8000 (J. T. Baker Chemical Co., Phillipsburg, NJ) was added. One hour later the tubes were centrifuged at 2500 x g for 30 min. The supernatants were aspirated and the precipitate counted in a well type y spectrometer. The RIA system showed no cross-reaction with ovine growth hormone, ovine prolactin, rat growth hormone, porcine relaxin, oxytocin, vasopressin, glucagon, insulin, submandibular gland renin, angiotensin 11, or epidermal growth factor when tested at maximal concentrations of 1 pg/tube. The least detectable concentration of PNGF (defined as the point at which 10% displacement of 12'-PNGF by unlabeled PNGF was achieved) consistently ranged from 16 to 21 pgltube. Nonspecific binding was consistently less than 6%. Inter-and intraassay coefficients of variation were 5 and 6%, respectively.
PC-12 cell bioassay. PC-12 cells were cultured in medium consisting of 85% RPMI-1640 medium supplemented with 10% horse serum and 5% fetal calf serum, 100 pg/ml streptomycin, and 150 U/ml penicillin. For the neurite bioassay, cells maintained in log phase growth were washed with Ham's saline B and resuspended in RPMI buffer containing 3% horse serum. Aliquots of cells were cultured in the presence of synaptosomal extracts in the absence or presence of purified PNGF antibody. The bioassays were carried out in six well cluster dishes (Costar, Van Nuys, CA). Cells were inspected at the end of 24 h for a neurite outgrowth response.
Statistical analysis. All data were expressed as mean + SEM.
RIA parallelism was assessed by measurement of PNGF in varying amounts of synaptosomal extracts or other fractions to be tested (1 5-300 pl). The slopes of the regression lines (of percent labeled NGF binding versus NGF standard or volume of test material) were calculated after log-logit transformation and tested for significance using Student's t test. PNGF concentrations between age groups were compared using analysis of variance. Individual comparisons after analysis of variance were made using the Newman Keul's test. Significance was assumed at the 5% level ( p < 0.05).
RESULTS
The protocol used for isolation of synaptosomal fractions from mouse cerebral cortex is outlined in Figure 1A . The quality of synaptosomal fractions isolated at the 0.8 and 1.2 M sucrose interface was assessed by electron microscope examination. Representative micrographs of these interface fractions isolated from 26-day-old mouse cerebral cortex are shown in Figure I B. This fraction was found to be rich in synaptosomes, but small amounts of membrane sacs, isolated endoplasmic reticulum, synaptosoma1 membrane fragments, and mitochondria also were observed. The origin of membrane fragments and free mitochondria is not clear; they may be of nonsynaptosomal origin or may have arisen from rupture of synaptosomes during preparation.
SEs prepared from 2 1-day-old mouse cerebral cortices were examined for PNGF immunoreactivity. SE, when added in varying amounts, produced RIA displacement curves parallel to the purified PNGF standard (Fig. 2, upper panel) . The mean slope values for the regression lines generated by standard PNGF and synaptosomal extracts were -1.0 + 0.01 and -0.96 f 0.03, respectively ( p > 0.05). Extracts of the mitochondrial-rich fraction, however, produced a nonparallel line in the PNGF-RIA (Fig. 2, lower panel) . The mean slope values for the regression lines of standard PNGF and mitochondria1 extracts were -1.0 + 0.0 1 versus -0.72 f 0.02, respectively ( p < 0.05).
The existence of immunoreactive PNGF material in synaplosoma1 fractions was established by isolated 0.8 and 1.2 M sucrose interface organelles following initial homogenization of cerebral cortices in 0.25 M sucrose, a nonoptimal condition for obtaining synaptosomal fractions. For this purpose, half of the cerebral cortices removed from the same animals were homogenized in 0.32 M sucrose solution. Both of the 10% homogenates were processed as described in Figure 1A . Only SE produced a RIAdisplacement line parallel to the PNGF standard (Fig. 3) . The slope value for the regression line generated by nonsynaptosomal extract was -0.74 + 0.01 ( p < 0.05) relative to PNGF standard.
Because isolation of synaptosomal fractions involved several hours of homogenization and differential centrifugation proce- M sucrose and the other in 0.25 M sucrose. Both homogenates were ~i~. 2, PNGF immunoreactivity in synaptosomal and identically processed as in Figure 1A . PNGF content was assayed in fractions of mouse cerebral cortex. Synaptosomal (P2B) and mitochon-varying amounts of the extracts. A shows synaptosomal extract and B drial (P2C) fractions were isolated from 26-day-old mouse cerebral cortex shows nons~na~tosomal extract. Only synaptosomal extract (A) proas described in Figure 1A . 
The relative amounts of PNGF in whole brain, cortex, and The PNGF concentrations, expressed per milligram synaptoso-in each group) were injected intraventricularly with: a) 3 volume of ma1 protein, were higher in SEs than in whole brain or cortex sterile saline, b) 5 ng PNGF/mouse in 3 p1 saline (experiment I) or c) extracts. PNGF concentrations in synaptosomal extracts of 100 ng (PNGF/mouse) in 3 ~1 saline (experiment 2). Animals were mouse cerebral cortex measured during various stages of devel-sacrificed 16 h after the injection. Cerebral cortices were removed, pooled opment are shown in Figure 6 . The mean synaptosomal PNGF (five cortices/pool) and processed for synaptosomal isolation as described concentration was highest on postnatal day 12 and the content in Figure IA . See text for other details. decreased with increasing age. No significant differences were seen between days 2 1 and 32. In contrast to synaptosomal PNGF concentration, the protein content of SEs was unchanged from day 12 to 32.
Neurite outgrowth response to SE. To assess the biological activity of the synaptosomal PNGF, 100 mouse cerebral cortices from 12-day-old animals were processed as described in Figure  IA . Synaptosomal fractions were extracted in RPMI-1640 buffer
The relative distribution of PNGF in 26-day-old mouse brain. Extracts of whole brain, cerebral cortex, and synaptosomes of cerebral cortex were prepared in phosphate buffered saline as described in the text. PNGF concentrations were determined by RIA.
POSTNATAL AGE ( D a y s ) and concentrated by pressure dialysis against the same bufl'er using Diaflo ultrafiltration membrane IOYM (Amicon Corporation, Lexington, MA). PNGF concentrations equivalent to 4 g original cerebral cortex (wet weight) were added to wells containing PC-12 cells (1 x lo4 cells/ml). The neurite outgrowth response was observed after a 24-h incubation period (Fig. 7) . The positive neurite outgrowth response due to synaptosomal PNGF was completely inhibited by PNGF-antibody (Fig. 7 D and I [ ) . Three independent isolation procedures consistently yielded positive neurite response in the PC-12 cell bioassay system. In all cases neurite outgrowth was accompanied by PC-12 cell aggl-egation, but PNGF antibody had no influence on the cell-cell aggregation. DISCUSSION We chose cerebral cortex for our study since this region has been reported recently to contain NGF-responsive cholinergic neurons both in neonatal and adult animals (10). The protocol described in Figure 1A routinely yielded good synaptosorr~al preparations as judged by electron microscopic and morphological criteria. We avoided repeated washings and rehomogenization procedures hoping to minimize artifacts.
For synaptosomal PNGF quantification we used a newly cleveloped PNGF polyclonal antiserum consisting of at least two high affinity antibodies. The assay is sensitive to 16 26 , and 32) were processed for synaptosomal isolation as detailed in Figure 1A . Synaptosomal extracts were assayed for PNGF concentrations by RIA. Protein content in the extracts were measured by the method of Lowry rt a/. (25) . See text for other details.
LAKSHMANAN ET AL
A Fig. 7 . PC-12 bioassay for SE. Synaptosomal fractions isolated from 12-day-old mouse cerebral cortices were extracted in RPMI-1640 buffer and pressure dialyzed against the same buffer, as indicated in the text. Concentrations equivalent to 4 g original cortex wet weight were added to culture dishes containing 1 ml of PC-12 cell suspension (2 x lo4 cells). To assess the specificity of PNGF-induced neurite outgrowth, purified PNGF antibody was included in companion dishes. The neurite response was recorded after 24 h. Cells were photographed using a phase contrast microscope. Additions: none ( A , E ) ; SEs of two independent preparations (B, C, F, G); SE in the presence of 500 pg of purified PNGF antibody (D, H). Top row A-D = x 100 magnification, bottom row E-H = x200 magnification. synaptosomal fractions. Reports of the presence of NGF-specific receptors in synaptosomal fractions (2 1, 22), as well as specific retrograde axonal transport in CNS (14, 15) , prompted us to examine the extent of any artifact which might be induced by receptor binding in the synaptosomal preparations. Even when large amounts of PNGF (six to 10 times the whole brain PNGF concentration on day 2 I) were given intraventricularly, we were unable to alter the endogenous synaptosomal PNGF concentrations. This result suggests that PNGF is not freely diffusable from the intraventricular space to other brain regions and that the endogenous synaptosomal PNGF immunoreactivity did not represent contamination occurring during the tissue processing procedures. Preliminary studies revealed that the addition of purified PNGF at a concentration of 5 ng/ml in a 10% cortical homogenate prepared in 0.32 M sucrose did not influence the concentration of endogenous synaptosomal PNGF concentration.
Small, but significant, concentrations of PNGF were detected in whole brain, cortex, and synaptosomal fractions. The PNGF concentrations reported herein for cerebral cortex of 2 1-day-old mice were significantly lower than the levels reported earlier from our laboratory by Walker et a/. (3 I) . The difference presumably is attributable to methodological variations. In the present study we used a 145,000 g supernatant for PNGF quantification while Walker et a/. (31) used a 25,000 g supernatant fraction. In addition, the purified PNGF used in the present study was prepared by the method of Mobley et al. (26) , as modified by Chapman et a/. (27) , and was used for immunization, iodination, and as reference standard. Also, we used a newly developed higher affinity antiserum for the RIA system in the present study. Finally, we have taken special precautions to prevent NGF contamination from the submandibular gland, a tissue which contains relatively high concentrations of PNGF even during the weanling stage.
The relatively high concentration of PNGF in synaptosomal fractions, as opposed to whole brain or cerebral cortex, demonstrates that this growth factor is not uniformly distributed in brain tissue. Studies of PNGF concentrations in SEs during various stages of development showed that the concentrations of endogenous synaptosomal PNGF is higher on day 12 than at other ages investigated. We did not attempt to isolate synaptosomes from animals younger than 12 days since there is no morphological evidence for the existence of mature presynaptic nerve terminals in such young animals.
Synaptosomal extracts of 12-day-old mouse cortex consistently elicited neurite responses in the PC-12 bioassay. Moreover, this neurite outgrowth response was completely inhibited by PNGFantibody. Synaptosomal extracts also caused aggregation of the PC-12 cells, but this aggregation was insensitive to PNGF-anti-body. Further work is in progress to purify PNGF immunoreactivity from synaptic extracts free of aggregation factor(s).
In conclusion, in the present study we detected subnanogram quantities of PNGF in whole brain, cerebral cortex, and SEs of mouse cerebral cortex using a highly sensitive and specific PNGF-RIA system. PNGF in similar concentrations has been reported recently in different regions of rat brain by Korsching and Thoenen (32) . These investigators used a two-site RIA technique.
In addition, Shelton and Reichardt (33) have reported detection of PNGF-mRNA in mouse brain. Our results indicate that much of this PNGF material in CNS is localized to presynaptic nerve terminals. Whether PNGF is localized within specific nerve terminals and whether PNGF performs any localized neuromodulator or neurotransmitter-like functions on the presynaptic side of the synapse remain interesting aspects for further study.
